← Leaderboards
Richard W Yee
University Of Texas Hlth Sci Ctr Houston
$1,916,857
Attributed
$1,916,857
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $652.8K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,916,857 · 3
By mechanism
R01$1,619,093 · 1
K23$150,040 · 1
R41$147,724 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectComputersSyndromeGene MutationFamily GeneticsQuestionnairesPolymerase Chain ReactionCornea DisorderBiomedical Equipment DevelopmentCollectionEye BurnsCombatComplementary DnaBioengineering /Biomedical EngineeringAsthenopiaClinical Biomedical EquipmentDisease DiagnosisDevicesCategoriesEffective TherapyEnvironmentBackData Collection Methodology /Evaluation
Grant awards (8)
Micro-environment Glasses as a Treatment for CVS$47,724
R41 · FY2011 · EY · contact PI
MOLECULAR STUDIES OF THE THIEL-BEHNKE CORNEAL DYSTROPHY$594,999
R01 · FY2006 · EY · contact PI
MOLECULAR STUDIES OF THE THIEL-BEHNKE CORNEAL DYSTROPHY$420,861
R01 · FY2005 · EY
MOLECULAR STUDIES OF THE THIEL-BEHNKE CORNEAL DYSTROPHY$220,319
R01 · FY2005 · EY
MOLECULAR STUDIES OF THE THIEL-BEHNKE CORNEAL DYSTROPHY$11,664
R01 · FY2005 · EY
MOLECULAR STUDIES OF THE THIEL-BEHNKE CORNEAL DYSTROPHY$371,250
R01 · FY2004 · EY
Micro-environment Glasses as a Treatment for CVS$100,000
R41 · FY2004 · EY
MOLECULAR GENETIC STUDIES IN CORNEAL DYSTROPHIES$150,040
K23 · FY2000 · EY